Radiolabeled nano-peptides show specificity for an animal model of human PC3 prostate cancer cells

Clinics

Volumn 66, Issue 2, 2011, Pages 327-336

  Faintuch, Bluma Linkowski ^a   Núñez, Gustavo Eutimio Fernández ^a   Teodoro, Rodrigo ^a   Moro, Ana M ^a   Mengatti, Jair ^a  

^a INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

Author keywords

Human tumor PC 3 cells; Peptide; Radiolabeling; Technetium 99m; Tumor uptake

Indexed keywords

BOMBESIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE; NANOPARTICLE; RADIOISOTOPE; STREPTAVIDIN; TECHNETIUM 99M HYNIC BOMBESIN; TECHNETIUM 99M HYNIC-BOMBESIN; TECHNETIUM COMPLEX;

ANIMAL; ARTICLE; CHEMISTRY; DISEASE MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; MOUSE; NUDE MOUSE; PROSTATE TUMOR; RANDOMIZATION; SCINTISCANNING; TIME; TUMOR CELL LINE;

ANIMALS; BOMBESIN; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, NUDE; MOLECULAR IMAGING; MORPHOLINES; NANOPARTICLES; ORGANOTECHNETIUM COMPOUNDS; PROSTATIC NEOPLASMS; RADIOISOTOPES; RANDOM ALLOCATION; STREPTAVIDIN; TIME FACTORS;

EID: 79955488799     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000200024     Document Type: Article

References (33)

1. Trottier G, Lawrentschuk N, Fleshner NE. Prevention strategies in prostate cancer. Curr Oncol. 2010;17 Suppl 2:S4-S10.
2. Chopra A. [111In]-DOTA-Aminohexanoyl-[D-Phe6,Leu-NHCH2CH2 CH313, desMet14] BBN[6-14] [111In]Bomproamide]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2010 (2010 May 20).
3. Chanda N, Kattumuri V, Shuka R, Zambre A, Katti K, Upendran A, et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci U S A. 2010; 107:8760-8765, doi: 10.1073/pnas.1002143107.
4. Liu Z, Yan Y, Liu S, Wang F, Chen X. 18F, 64Cu, and 68Ga Labeled RGDBombesin Heterodimeric Peptides for PET Imaging of Breast Cancer. Bioconjugate Chem. 2009;20:1016-1025, doi: 10.1021/bc9000245.
5. Anastasi A, Espamer V, Bucci M. Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia. 1971;27:166-167, doi: 10.1007/BF02145873.
6. McDonald TJ, Jornvall H, Nilsson G, Vagne M, Ghatei M, Bloom SR, et al. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun. 1979; 90:227-233, doi: 10.1016/0006-291X(79)91614-0.
7. Flores DG, Lenz G, Roesler R, Schwartsmann G. Gastrin-releasing peptide receptor signaling in cancer. Cancer Therapy. 2009;7: 332-346.
8. Parry JJ, Andrews R, Rogers BE. Micro PET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor. Breast Cancer Res Treat. 2007;101: 175-183, doi: 10.1007/s10549-006-9287-8.
9. Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Nucl Med Biol. 2008;35:401-411.
10. Van de Wiele C, Dumont F, Diercks RA, Peers SH, Thornback JR, Slegers G, et al. Biodistribution and dosimetry of 99mTc-RP527, a gastrinreleasing peptide (GRP) agonist for the visualization of GRP receptorexpressing malignancies. J Nucl Med. 2001;42: 1722-1727.
11. Mang'era KO, Liu G, Yi W, Zhang Y, Liu N, Gupta S, et al. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications. Eur J Nucl Med. 2001;28:1682-1689.
12. Liu G, Liu C, Zhang S, He J, Liu N, Gupta S, et al. Investigations of 99mTc morpholino pretargeting in mice. Nucl Med Commun. 2003;24:697-705, doi: 10.1097/00006231-200306000-00013.
13. Wang Y, Liu X, Nakamura K, Chen L, Rusckowski M, Hnatowich DJ. In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles. Cancer Biother Radiopharm. 2009;24: 573-578, doi: 10.1089/cbr.2009.0624.
14. Liu G, He J, Dou S, Gupta S, Rusckowski M, Hnatowich DJ. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor. Eur J Nucl Med Mol Imaging. 2005; 32:1115-1123,doi: 10.1007/s00259-005-1853-5.
15. Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Kannan R, et al. Radiochemical investigations of gastrin-releasing peptide receptorspecific[(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: Syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3. Cancer Res. 2003;63:4082-4088.
16. Lane SR, Veerendra B, Rold TL, Sieckman GL, Hoffman TJ, Jurisson SS, et al. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor. Nucl Med Biol. 2008;35:263-272, doi: 10.1016/j.nucmedbio.2007.11.007.
17. Rogers BE, Manna DD, Safavy A. In vitro and in ivo evaluatin of a 64Culabeled polyethythylene glycol-bombesin conjugate. Cancer Biother Radiopharm. 2004;19:25-34, doi: 10.1089/108497804773391649.
18. Smith CJ, Gali H, Sieckman GL, Higginbotham C, Volkert WA, Hoffman TJ. Radiochemical Investigations of 99mTc2N3S-X-BBN[7214]NH2: An in Vitro/in Vivo Structure2Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties. Bioconjugate Chem. 2003;14: 93-102, doi: 10.1021/bc020034r.
19. Wang Y, Liu X, Hnatowich DJ. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with (99m)Tc at room temperature. Nat Protoc. 2007;2:972-978, doi: 10.1038/nprot.2007.144.
20. Liu G, Mang'era K, Liu N, Gupta S, Rusckowski M, Hnatowich DJ. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog. J Nucl Med. 2002;43:384-391.
21. Liu G, Dou S, He J, Liu X, Rusckowski M, Hnatowich DJ. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice. Eur J Nucl Med Mol Imaging. 2007;34:237-246, doi: 10.1007/s00259-006-0222-3.
22. Reile H, Armatis PE, Schally AV. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145:internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. Prostate. 1994;25:29-38, doi: 10.1002/pros.2990250105.
23. Montet X, Yuan H, Weissleder R, Josephson L. Enzyme-based visualization of receptor-ligand binding in tissues. Lab Invest. 2006;86:517-525, doi:10.1038/labinvest.3700404.
24. Akizawa H, Uehara T, Arano Y. Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins. Adv Drug Deliv Rev. 2008;60:1319-1328, doi:0.1016/j.addr.2008.04.005.
25. Liu G, He J, Dou S, Gupta S, Vanderheyden JL, Rusckowski M, et al. Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake. Eur J Nucl Med Mol Imaging. 2004;31:417-424, doi: 10.1007/s00259-003-1393-9.
26. Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Kannan R, et al. Radiochemical investigations of [99mTc(H2O)(CO)3-Dpr-(X)-Bombesin(7- 14)NH2], a newfamily of GRP-receptor targeting radiopharmaceuticals. In: Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine - Marino Nicolini Uderico Mazzi, 2002:339-44.
27. Rolleman EJ, Valkema R, de Jong M, Kooij PP, Krenning EP. Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine. Eur J Nucl Med Mol Imaging. 2003;30:9-15, doi: 10.1007/s00259-002-0982-3.
28. Schuhmacher J, Zhang H, Doll J, Mäcke HR, Matys R, Hauser H, et al. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin (6-14) analog. J. Nucl Med. 2005;46:691-699.
29. La Bella R, Garayoa EG, Bahler M, Blauenstein P, Schibli R, Conrath P, et al. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjugate Chem. 2002;13:599-604, doi:10.1021/bc015571a.
30. Maina T, Nock BA, Zhang H, Nikolopoulou A, Waser B, Reudi JC. Species differences of bombesin analog interactions with GRP-Rdefine the choice of animal models in the development of GRP-R-targeting drugs. J Nucl Med. 2005;46:823-830.
31. De Vincentis G, Remediani S, Varvarigou AD, Di Santo G, Iori F, Laurenti C, et al. Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer. Cancer Biother Radiopharm. 2004; 19:81-84, doi: 10.1089/108497804773391711.
32. Scopinaro F, De Vincentis G, Varvarigou AD, Laurenti C, Iori F, Remediani S, et al. 99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes. Eur J Nucl Med Mol Imaging. 2003;30:1378-1382,doi: 10.1007/s00259-003-1261-7.
33. Jain R, Dandekar P, Patravale V. Diagnostic nanocarriers for sentinel lymph node imaging. J Control Release. 2009;138:90-102, doi: 10.1016/j.jconrel.2009.05.010.